- Home
- Publications
- Publication Search
- Publication Details
Title
Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-09-14
DOI
10.1093/cid/ciz770
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018
- (2019) Elisabeth M. Hesse et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study
- (2019) Kelly D. Johnson et al. BMC PUBLIC HEALTH
- Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention
- (2018) Nicolas Lecrenier et al. Expert Review of Vaccines
- Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
- (2018) Anthony L Cunningham et al. JOURNAL OF INFECTIOUS DISEASES
- Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older
- (2018) Desmond Curran et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial
- (2018) Céline Maréchal et al. VACCINE
- Adherence with and completion of recommended hepatitis vaccination schedules among adults in the United States
- (2018) Laurel Trantham et al. VACCINE
- Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults
- (2018) Tino F. Schwarz et al. Human Vaccines & Immunotherapeutics
- Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
- (2018) Kathleen L. Dooling et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Th1 memory differentiates recombinant from live herpes zoster vaccines
- (2018) Myron J. Levin et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older
- (2017) Tino F Schwarz et al. JOURNAL OF INFECTIOUS DISEASES
- Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
- (2017) Benjamin Mordmüller et al. NATURE
- Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
- (2017) Margherita Coccia et al. npj Vaccines
- Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years
- (2016) Hung Fu Tseng et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
- (2016) Anthony L. Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults
- (2016) Roman Chlibek et al. VACCINE
- Central Role of CD169+ Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01
- (2016) Sophie Detienne et al. Scientific Reports
- Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
- (2015) Himal Lal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination
- (2015) Geert Leroux-Roels et al. VACCINE
- Effector and Central Memory Poly-Functional CD4+ and CD8+ T Cells are Boosted upon ZOSTAVAX® Vaccination
- (2015) Janet J. Sei et al. Frontiers in Immunology
- Long-term Persistence of Zoster Vaccine Efficacy
- (2014) Vicki A. Morrison et al. CLINICAL INFECTIOUS DISEASES
- Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells
- (2014) Arnaud M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study
- (2014) Elchonon M. Berkowitz et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study
- (2014) Roman Chlibek et al. VACCINE
- Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age
- (2013) R. Chlibek et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years
- (2012) K. E. Schmader et al. CLINICAL INFECTIOUS DISEASES
- A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults
- (2012) Isabel Leroux-Roels et al. JOURNAL OF INFECTIOUS DISEASES
- Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice
- (2012) Najoua Dendouga et al. VACCINE
- Influence of Age and Nature of Primary Infection on Varicella‐Zoster Virus–Specific Cell‐Mediated Immune Responses
- (2010) Adriana Weinberg et al. JOURNAL OF INFECTIOUS DISEASES
- Varicella-Zoster Virus Glycoprotein E Is a Critical Determinant of Virulence in the SCID Mouse-Human Model of Neuropathogenesis
- (2010) L. Zerboni et al. JOURNAL OF VIROLOGY
- Varicella‐Zoster Virus–Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine
- (2009) Adriana Weinberg et al. JOURNAL OF INFECTIOUS DISEASES
- Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine
- (2008) M. J. Levin et al. JOURNAL OF INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now